临床前CDMO研发筛选相关化合物如有产品调研服务, 请致函联系我们
客户展示
临床前CDMO研发化合物筛选
Abacavir (1592U89)
中文名称:阿巴卡韦
CAS号:136470-78-5
分子式: C14H18N6O 分子量: 286.33
产品形式: free base
研发状态: Completed
研发用途: HIV-1 Infection
研究机构: ANRS Emerging Infectious Diseases; ViiV Healthcare
研发日期: February 10 2020
研发阶段: Not Applicable
Abacavir (1592U89, ABC) is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS.
Tetracaine HCl
中文名称:盐酸丁卡因
CAS号:136-47-0
分子式: C15H24N2O2.HCl 分子量: 300.82
产品形式: Hydrochloride
研发状态: Active not recruiting
研发用途: Intratympanic Steroid Injection; Idiopathic Sudden Sensorineural Hearing Loss; Meniere Disease
研究机构: Our Lady of the Lake Hospital; Louisiana State University Health Sciences Center - New Orleans
研发日期: August 1 2021
研发阶段: Early Phase 1
Tetracaine HCl (Amethocaine hydrochloride) is a hydrochloride salt form of tetracaine which is a potent local anaesthetic and a channel function allosteric inhibitor.
Phenazopyridine HCl
中文名称:盐酸非那吡啶
CAS号:136-40-3
分子式: C11H11N5.HCl 分子量: 249.70
产品形式: Hydrochloride
研发状态: Unknown status
研发用途: Human Volunteers
研究机构: Universal Enterprises
研发日期: Aug-08
研发阶段: Not Applicable
Phenazopyridine HCl is a local analgesic that has been used in urinary tract disorders. It is an inhibitor of sodium channel protein type 1 subunit alpha.
Seletalisib (UCB-5857)
中文名称:司来利塞
CAS号:1362850-20-1
分子式: C23H14ClF3N6O 分子量: 482.85
产品形式: Free Base
研发状态: Completed
研发用途: Healthy Volunteers
研究机构: UCB Celltech; Parexel; UCB Pharma
研发日期: Aug-14
研发阶段: Phase 1
Seletalisib (UCB-5857) is a novel small-molecule inhibitor of PI3Kδ with an IC50 value of 12 nM and shows significant selectivity to PI3Kδ with respect to the other class I PI3K isoforms (between 24- and 303-fold).
Rasagiline
中文名称:雷沙吉兰
CAS号:136236-51-6
分子式: C12H13N 分子量: 171.24
产品形式: Free Base
研发状态: Completed
研发用途: Major Depressive Disorder; Treatment Resistant Depression
研究机构: Centre for Addiction and Mental Health
研发日期: April 15 2021
研发阶段: Not Applicable
Rasagiline (TVP-1012) is a novel selective and irreversible MAO-B propargylamine inhibitor with in vitro IC50s of 4.43 nM and 412 nM for MAO-B and MAO-A, respectively.
TP-3654
中文名称:反式-A,A-二甲基-4-[[3-[3-(三氟甲基)苯基]咪唑[1,2-B]哒嗪-6-基]氨基]环己醇
CAS号:1361951-15-6
分子式: C22H25F3N4O 分子量: 418.46
产品形式: Free Base
研发状态: Completed
研发用途: Healthy
研究机构: Sumitomo Pharma America Inc.
研发日期: May 22 2023
研发阶段: Phase 1
TP-3654 is the second-generation PIM inhibitor with Ki values of 5 nM, 239 nM, and 42 nM for PIM-1, PIM-2 and PIM-3, respectively.
我们的宗旨: 净化, 简洁, 高效Purifying, concise, efficient !我们的口号: 减少中间商赚差价!
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
分类广告投放
依据化学成分的不同, 针对不同的企业和产品, 我们提供分类产品广告投放.客户展示
优秀企业推荐
